Literature DB >> 17686874

Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.

Tania Crough1, Chrysa Fazou, Julissa Weiss, Scott Campbell, Miles P Davenport, Scott C Bell, Andrew Galbraith, Keith McNeil, Rajiv Khanna.   

Abstract

Using ex vivo antigen-specific T-cell analysis, we found that symptomatic cytomegalovirus recrudescence in transplant recipients was coincident with reduced expression of gamma interferon (IFN-gamma) by virus-specific CD8(+) T cells and an up-regulation of CD38 expression on these T cells, although there was no significant change in the absolute number of virus-specific cells (as assessed by major histocompatibility complex-peptide multimers). In contrast, HLA class I-matched transplant patients with asymptomatic viral recrudescence showed increased expansion of antigen-specific T cells and highly stable IFN-gamma expression by epitope-specific T cells. These studies suggest that a strong functional T-cell response plays a crucial role in defining the clinical outcome of acute viral recrudescence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686874      PMCID: PMC2045544          DOI: 10.1128/JVI.00581-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

Authors:  Simon F Lacey; Don J Diamond; John A Zaia
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742

2.  Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.

Authors:  Tania Crough; Jacqueline M Burrows; Chrysa Fazou; Susan Walker; Miles P Davenport; Rajiv Khanna
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

3.  Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

Authors:  S L Silins; M A Sherritt; J M Silleri; S M Cross; S L Elliott; M Bharadwaj; T T Le; L E Morrison; R Khanna; D J Moss; A Suhrbier; I S Misko
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

4.  Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.

Authors:  M E Paul; W T Shearer; C A Kozinetz; D E Lewis
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

5.  Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.

Authors:  Z Liu; W G Cumberland; L E Hultin; H E Prince; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-10-01

Review 6.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

7.  Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

Authors:  Rebecca Elkington; Susan Walker; Tania Crough; Moira Menzies; Judy Tellam; Mandvi Bharadwaj; Rajiv Khanna
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 8.  Vaccine strategies against human cytomegalovirus infection.

Authors:  Jie Zhong; Rajiv Khanna
Journal:  Expert Rev Anti Infect Ther       Date:  2007-06       Impact factor: 5.091

9.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  16 in total

1.  T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.

Authors:  Corey Smith; Dillon Corvino; Leone Beagley; Sweera Rehan; Michelle A Neller; Pauline Crooks; Katherine K Matthews; Matthew Solomon; Laetitia Le Texier; Scott Campbell; Ross S Francis; Daniel Chambers; Rajiv Khanna
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

2.  EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.

Authors:  Camila Macedo; Steven A Webber; Albert D Donnenberg; Iulia Popescu; Yun Hua; Michael Green; David Rowe; Louise Smith; Maria M Brooks; Diana Metes
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

3.  A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.

Authors:  Vijayendra Dasari; Kirrilee Beckett; Shane Horsefield; George Ambalathingal; Rajiv Khanna
Journal:  PLoS Pathog       Date:  2022-06-23       Impact factor: 7.464

4.  Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Authors:  Davide Abate; Alda Saldan; Carlo Mengoli; Marta Fiscon; Cristina Silvestre; Loredana Fallico; Marta Peracchi; Lucrezia Furian; Riccardo Cusinato; Luciana Bonfante; Barbara Rossi; Francesco Marchini; Dino Sgarabotto; Paolo Rigotti; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

5.  CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection.

Authors:  Christopher M Snyder; Andrea Loewendorf; Elizabeth L Bonnett; Michael Croft; Chris A Benedict; Ann B Hill
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

Review 6.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.

Authors:  Sara Cantisán; Julián Torre-Cisneros; Rosario Lara; Alberto Rodríguez-Benot; Francisco Santos; Juan Gutiérrez-Aroca; Inmaculada Gayoso; Marcelino González-Padilla; Manuel Casal; Antonio Rivero; Rafael Solana
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

8.  Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.

Authors:  Jie Zhong; Michael Rist; Leanne Cooper; Corey Smith; Rajiv Khanna
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

9.  Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people.

Authors:  Evelyna Derhovanessian; Andrea B Maier; Karin Hähnel; Henning Zelba; Anton J M de Craen; Helene Roelofs; Eline P Slagboom; Rudi G J Westendorp; Graham Pawelec
Journal:  Age (Dordr)       Date:  2012-06-04

10.  Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.

Authors:  Corey Smith; Stephanie Gras; Rebekah M Brennan; Nicola L Bird; Sophie A Valkenburg; Kelly-Anne Twist; Jacqueline M Burrows; John J Miles; Daniel Chambers; Scott Bell; Scott Campbell; Katherine Kedzierska; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna
Journal:  Sci Rep       Date:  2014-02-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.